Literature DB >> 18615582

S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines.

Maria Radu1, Dianne R Soprano, Kenneth J Soprano.   

Abstract

All trans retinoic acid (atRA) has been shown to inhibit the growth of CAOV3 ovarian carcinoma cells and to elevate the level of p27 cyclin-dependent kinase inhibitor. We report here that phosphorylation at S10 residue is an important event in mediating p27 role in atRA induced growth arrest. atRA treatment of atRA sensitive CAOV3 cells increases the levels of S10 phospho-p27 in both nuclear and cytoplasmic cell compartments. This increase is accompanied by a decrease in the levels of skp2 protein. This effect was not observed in SKOV3 cells which are resistant to atRA growth inhibitory effect. An A10-p27 mutant that cannot be phosphorylated at S10 induces a dominant negative effect on the atRA effect on the levels and activity of endogenous p27. Overexpression of A10-p27 mutant renders CAOV3 cells more resistant to atRA treatment and reverses the effect that atRA has on p27 binding to CDKs, on CDK activity, and on the expression of S phase genes. (c) 2008 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18615582      PMCID: PMC2575059          DOI: 10.1002/jcp.21532

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  34 in total

1.  Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability.

Authors:  N Ishida; M Kitagawa; S Hatakeyama; K Nakayama
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.

Authors:  G Rodier; A Montagnoli; L Di Marcotullio; P Coulombe; G F Draetta; M Pagano; S Meloche
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Translational control of p27Kip1 accumulation during the cell cycle.

Authors:  L Hengst; S I Reed
Journal:  Science       Date:  1996-03-29       Impact factor: 47.728

4.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

5.  All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1.

Authors:  S Wu; A Donigan; C D Platsoucas; W Jung; D R Soprano; K J Soprano
Journal:  Exp Cell Res       Date:  1997-05-01       Impact factor: 3.905

6.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

7.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.

Authors:  Incheol Shin; F Michael Yakes; Federico Rojo; Nah-Young Shin; Andrei V Bakin; Jose Baselga; Carlos L Arteaga
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

8.  Antiproliferative activity of retinoic acid and some novel retinoid derivatives in breast and colorectal cancer cell lines of human origin.

Authors:  F Kaleagasioglu; G Doepner; H K Biesalski; M R Berger
Journal:  Arzneimittelforschung       Date:  1993-04

9.  p27/Kip1 mediates retinoic acid-induced suppression of ovarian carcinoma cell growth.

Authors:  Scott Vuocolo; Dianne Robert Soprano; Kenneth J Soprano
Journal:  J Cell Physiol       Date:  2004-05       Impact factor: 6.384

10.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  6 in total

1.  Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.

Authors:  Anthony A Cuneo; David Herrick; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2010-05-06       Impact factor: 5.000

2.  Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.

Authors:  Y Lu; S Bertran; T-A Samuels; R Mira-y-Lopez; E F Farias
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

Review 3.  Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells.

Authors:  X T Hu; K S Zuckerman
Journal:  Cell Prolif       Date:  2014-03-19       Impact factor: 6.831

4.  Involvement of RBP4 in all‑trans retinoic acid induced cleft palate.

Authors:  Shiyi Dong; Yadong Zhang; Hongzhang Huang
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

5.  Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse.

Authors:  Fieke W Hoff; Chenyue W Hu; Amina A Qutub; Yihua Qiu; Marisa J Hornbaker; Carlos Bueso-Ramos; Hussein A Abbas; Sean M Post; Eveline S J M de Bont; Steven M Kornblau
Journal:  Proteomics Clin Appl       Date:  2019-02-04       Impact factor: 3.494

6.  p27(Kip1) and Ser10-phosphorylated p27(Kip1) in breast cancer: clinical significance and expression.

Authors:  Wei Song; Ruilian Xie; Aiyu Zhu; Yumei Xu; Yaqin Shi; Yan Shen; Wenwen Zhang; Fang Yang; Xiaoxiang Guan
Journal:  Onco Targets Ther       Date:  2015-07-24       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.